Andrea Park
Vermögen: - $ am 28.02.2026
Vermögen: - $ am 28.02.2026
Ms. Andrea E.
Park was previously employed as a Chief Financial Officer by AlphaTON Capital Corp., a Chief Financial Officer by AgeX Therapeutics, Inc., a Vice President-Finance & Controller by Lineage Cell Therapeutics, Inc., and a Chief Financial & Accounting Officer by Serina Therapeutics, Inc. She received her undergraduate degree from the University of California.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.07.2025 | 0 ( -.--% ) | - $ | 28.02.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALPHATON CAPITAL CORP. | Finanzdirektor/CFO | 24.10.2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.09.2019 |
| AGEX THERAPEUTICS, INC. | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
AlphaTON Capital Corp.
AlphaTON Capital Corp. BiotechnologyHealth Technology Operates as an immuno oncology company | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition